IFF Receives All Required Antitrust Clearances for Intended
Combination with DuPont’s Nutrition & Biosciences Business Transaction remains on track to close in first quarter of 2021
IMAGE CREDIT: Nick Roskelly
IFF and DuPont announced that the intended combination of DuPont’s Nutrition & Biosciences (N&B) business with IFF has received unconditional clearance from the European Commission. With receipt of this clearance, the intended combination has received all required antitrust clearances and approvals that are a condition to the closing of the transaction.
IFF and DuPont continue to expect to close the transaction in the first quarter of 2021.
Looking for a reprint of this article?
From high-res PDFs to custom plaques, order your copy today!
